Der Gitlabfounder hatte auch Krebs, Knochenkrebs, seine Krebsdaten hat er Freigegeben und ne Lösung gefunden:

Hier seine Daten:
https://osteosarc.com/

Hier die Story:
https://centuryofbio.com/p/sid

While radiotherapy can sound extreme, Sid found it dramatically more tolerable than chemotherapy. The experiences were as different as night and day. Rather than spreading throughout his entire body and wreaking havoc, the radiotherapy primarily concentrated at the site of his tumor. After getting out of quarantine, Sid got busy planning a wine tasting to celebrate.

Sid and his team were astonished by the difficulty of achieving both tasks.

Pathology departments prefer to run standard protocols. Cryopreservation is not standard. Accommodating this introduced novelty and risk. What if they made a mistake? Would they be liable?

Sid described the “incredible struggle at every hospital” to get access to his own tissue. Doing so has required “forward deployed tissue extractors,” who navigate hospital bureaucracy and don’t take no for an answer until they get sign-off and transfer. It is still a major struggle to access and move around historical samples.

Surprisingly, hospital institutional review boards (IRBs) have been more challenging to navigate than the FDA. Sid describes it as a “vetocracy” where one member of the board can block treatment based on even the smallest concern. Large hospital systems, which are concerned with adhering to procedures and avoiding liability, have strong organizational antibodies to mitigate any threat of risk. Still, Sid has found drug repurposing to be a powerful tool in his arsenal.

In December of 2023, Moderna publishedincredible clinical resultsshowing that their version of this process, in combination with a checkpoint inhibitor, cut the risk of cancer recurrence or deathnearly in halffor melanoma patients.

While these results are remarkable, there is still enormous room for improvement. Much like early computers, these therapies are still too expensive and slow for broader adoption. And they still aren’t delivering the types ofcompleteresponses that CAR-T therapies have now repeatedly achieved.

Wirklich lesenswerter artikel:
https://centuryofbio.com/p/sid

Man kann heutzutage sein Genom für unter 250 USD 
https://www.writingruxandrabio.com/p/why-havent-biologists-cured-cancer

Wahnsinns Fortschritte:

https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2026/2026-cancer-facts-and-figures.pdf

Und warum Bürokratie Krebsforschung so schwer macht: 
https://www.writingruxandrabio.com/p/the-bureaucracy-blocking-the-chance